Search global stocks & ETFs...Ctrl K
Learn Mode
GMED
Stock Profile
08-06
Recommended Metric
Score Card
Explore Scores Tab
4.00
Good
Valuation Score
Key Score
4.00
Good
Management
5.00
Very Good
Growth
3.00
Average
Profitability
5.00
Very Good
Fin. Health
4.00
Good
Dividends
--
--
Analyst
1.00
Very Bad
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending Jun 28, 2027
Current
$78.79
Baseline
High
$128.10
▲
62.58%
Avg
$110.08
▲
39.71%
Low
$87.87
▲
11.52%
Analyst Ratings based on 21 Analysts
Strong Buy
419%
Buy
1152%
Hold
629%
Sell
000%
Strong Sell
000%
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 6,000 full-time employees. The company went IPO on 2012-03-08. The firm provides education and clinical support, and advanced care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. The firm offers a comprehensive portfolio of technologies that address a variety of musculoskeletal pathologies, anatomies, and surgical approaches. The company separates its products and services into two major categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, surgical instruments, spinal cord stimulation treatment therapy, and neuromonitoring services, used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery which are advanced computer-assisted intelligent systems designed to enhance a surgeon’s capabilities.Read More